Muro3.gif

 

マウス・ラット用
無加温型非観血式血圧計

Model MK-2000ST

Introducing the first and only Non-Preheating, Non-Invasive

Blood Pressure Monitor for Mice and Rats


Capable of recording from neonatal mice (1.4 g) to the aged rats (1 kg)

ラットやマウス等の小動物の血圧を測定する場合、従来の非観血式血圧計では何らかの方法により動物を暖めておく必要がありました。これに対しMK-2000STは室温が23℃以上あれば自然の(無加温の)状態のままで測定を行なうことができます薬物の影響を調べるのに最適な装置であり、尾動脈圧の経時変化をモニタすることもできるなど従来の非観血式血圧計の概念を覆す画期的な装置です。操作は至って簡単で、動物を測定台にセットした後はボタンを押すだけの全自動測定が行なえます。

主な特長

MODE1 HR SBP
MODE2 HR SBP MBP (DBP)

注:HR(脈拍数)、SBP(収縮期血圧)、MBP(平均血圧)、DBP(拡張期血圧、計算値)

 


Correlation between simultaneously recorded blood pressures (BP) from carotid catheter and BP measured with the Model MK-2000 in mice. Good correlation was seen in a wide range of BP, which was induced by i.v. infusions of pressor or depressor agents.

 

図1 血圧データ(観血法およびMK-2000)

図2 観血法との相関  mk2000/図3 心拍数

The data was offered courtesy of Prof. Tomoyuki Kuwaki, Ph.D.,
Department of Molecular and Integrative Physiology, Graduate School of Medicine,
Chiba University


仕 様

本        体
SBP パルス出現点のカフ圧
MBP 減圧時におけるパルスの最大振幅点のカフ圧
DBP 計算値 (3MBP-SBP)/2
センサ部 LED,  フォトトランジスタ
加圧範囲 0 - 350mm Hg
記 録 紙 感熱記録紙、58mm幅(TSP-10)
印字内容 日付、時間、動物番号、体重
測定モード、測定間隔、測定回数
測定項目及び平均値とSD値、計測時刻
電  源 AC100V 50/60Hz
外形寸法 210W × 310D × 210 mmH
重  量 約 8 kg

 

キーボード
キー 33
外形寸法 145W × 120D × 20 mmH
重  量 約 0.4 kg

 

標 準 構 成
本体(プリンタ含む) 1
キーボード 1
ラット用測定台 1
アニマルホルダ(任意の1ケ選択) 1
カフパルス・センサ(任意の1ケ選択) 1
TSP-10 記録紙 (5巻入) 1
APC-2000 アクセサリケース 1
ダストカバー 1

 

アニマルホルダ
Mouse Holder (3S) 5-10g
Mouse Holder (SS) 10-20g
Mouse Holder (S) 20-30g
Mouse Holder (M) 30-40g
Mouse Holder (L) 40-50g
Rat Holder (3S) 50-70g
Rat Holder (SS) 70-90g
Rat Holder (S) 90-150g
Rat Holder (SM) 150-210g
Rat Holder (M) 210-270g
Rat Holder (ML) 270-350g
Rat Holder (L) 350-500g
Rat Holder (LL) 500-800g
カフパルスセンサ
Neo24NH 1.4 - 2g
Neo32NH 2 - 5g
Neo40NH

5 - 10g

Mouse NH 20-50g
OB Mouse NH OB Mouse & Mouse 5-20g
C57 Mouse NH C57BL6 Mouse
Hamster (S) NH Approx.  60-80g
Hamster (M) NH Approx.  80-120g
Hamster (L) NH Approx.120-160g
Rat (S)NH 90-210g
Rat (M)NH 210-350g
Rat (ML)NH 350-500g
Rat (L)NH 500-800g

 

    * 特別仕様のアニマルホルダも製作致します。    

外観及び仕様は改良のため予告なしに変更する場合がありますのでご了承願います。

 

REFERENCES:

  1. Design and production of genetically modified soybean protein with anti-hypertensive activity by incorporating potent analogue of ovokinin (2-7) (FEBS Letters 24860 (2001) 1-5
    Nobuyuki Matoba, Naomi Doyama, Yuko Yamada, Nobuyuki Maruyama, Shigeru Utsumi,  Masaaki Yoshikawa
    Research Institute For Food Science,  Kyoto University,  Uji  Kyoto 611-0011, Japan

    Animal used : SHR
     

  2. Design of a Highly Potent Anti-hypertensive Peptide Based on Ovokinin(2-7) (Biosci. Biotechnol. Biochem.,66(6), 1213-1217,2002)
    Yuko Yamada, Nobuyuki Matoba, Hachiro Usui, Kunihiko Onishi, and Masaaki Yoshikawa
    Division of Food Bioscience and Biotechnology, Graduate School of Agriculture, Kyoto University, Uji, Kyoto 611-0011, Japan
    Animal used : SHR and Wky Rat
     

  3. Syndecan-4 Deficiency Leads to High Mortality of Lipopolysaccharide-injected Mice (The Journal of Biological Chemistry, Vol. 276, No. 50, Issue of December 14, pp. 47483-47488, 2001)
    Kazuhiro Ishiguro‡§,  Kenji Kadomatsu,  Tetsuhito Kojima||,  Hisako Muramatsu‡,  Mitsunori Iwase||,
    Yasunobu Yoshikai**,  Masamitsu Yanada‡§,  Koji Yamamoto§, Tadashi  Matsushita§,  Masahiko Nishimura‡‡
    Kazuo Kusugami§,  Hidehiko Saito§ §§,  and Takashi Muramatsu¶¶
    From the ‡Department of Biochemistry, §First Department of Internal Medicine, **Laboratory of Host Defense & Germfree Life, Research Institute for Disease Mechanism and Control, and ‡‡Institute for Laboratory Animal Research, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan, the ||Department of  Medical Technology, Nagoya University School of Health Sciences, 1-1-20 Daiko-Minami, Higashi-ku, Nagoya, Aichi, 461-8673,Japan, and the §§Nagoya National Hospital, 4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi, 460-0001, Japan
     

  4. Validity and Application of Noninvasive Measurement of Blood Pressure in Hamsters (Exp.Anim. 52(4), 359-363, 2003)
    Kato Y,  Iwase M,  Kanazawa H,  Nishizawa T,  Zhao YL,  Takagi K,  Nagata K,  Noda A,  Koike Y,  Yokota M
    School of Health Sciences, Nagoya University, 1-1-20 Daiko-minami, Higashi-ku, Nagoya 461-8673, Japan.
     

  5. Progressive Development of Pulmonary Hypertension Leading to Right Ventricular Hypertrophy Assessed by Echocardiography in Rats (Exp. Anim. 52(4), 285-294, 2003)
    Yosuke KATO1), Mitsunori  IWASE1), Hiroaki  KANAZAWA1),  Natsuki  KAWATA1) ,Yukie YOSHIMORI,1)
    Katsunori HASHIMOTO1),  Toyoharu YOKOI1),  Akiko NODA1),  Kenzo TAKAGI1),  Yasuo KOIKE1),
    Takao NISHIZAWA2),  Masahiko NISHIMURA2), and Mitsuhiro YOKOTA2)
    1)School of Health Science, Nagoya University,1-1-20 Daiko-minami,Higashi-ku, Nagoya 461-8673, and,
    2)Graduate School of Medicine, NagoyaUniversity,65 Tsurumai-cho, Showa-ku,Nagoya 466-8550,Japan

     

  6. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth (The Journal of Clinical Investigation July 2003 Vol.112, No. 1)
    Kimiyasu Egami,1,2 Toyoaki Murohara,1,3,4 Toshifumi Shimada,1,3 Ken-ichiro Sasaki,1,3
    Satoshi Shintani,1,3 Takeshi Sugaya,5 Masahiro Ishii,1,2 Teiji Akagi,1,2 Hisao Ikeda,1,3
    Toyojiro Matsuishi,1,2 and Tsutomu Imaizumi1,3
    1 The Cardiovascular Research Institute,
    2 Department of Pediatrics, and
    3 Department of Internal Medicine III, Kurume University School of Medicine, Kurume, Japan
    4 Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    5 Discovery Research Laboratory, Tanabe Seiyaku Co., Osaka, Japan
    Animal used : C57BL6 Mouse
     

  7. Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters  (Cardiovascular Research 61 (2004) 30-38)
    Iwase, M., Kanazawa, H., Kato, Y., Nishizawa, T., Somura, F., Ishiki, R., Hagata, K., Hashimoto, K., Takagi, K., Izawa, H. and Yokota,
     

  8. Development of an in vivo Bioassay Method for Allergy-Preventive Substances using HEL-induced Blood Flow Decrease (Biol. Pharm. Bull)
    Kyoko Ishiguro1), Hisae Oku1), Yoshimi Ueda1), Emiko Iwaoka1) and Masaru Kunitomo1)
    1) School of Pharmaceutical Sciences, Mukogawa Women's University
    Animal used : ddY Mouse
     

  9. Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle (NATURE MEDICINE Volume 10 Number 11  November 2004)
    Takahiro Iwamoto1,3, Satomi Kita1,5, Jin Zhang2, Mordecai P Blaustein2, Yuji Arai4, Shigeru Yoshida5,
    Koji wakimoto6, Issei Komuro7&Takeshi Katsuragi1
    1 Department of Pharmacology, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
    2 Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
    3 Department of Molecular Physiology, National Cardiovascular Center Research Institute, Osaka 565-8565, Japan.
    4 Department of Bioscience, National Cardiovascular Center Research Institute, Osaka 565-8565, Japan.
    5 Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Saitama 330-8530, Japan.
    6 Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd., Osaka 532-8505, Japan.
    7 Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
    Animal used : C57BL6 Mouse
     

  10. The vascular relaxing effects of sevoflurane and isoflurane are more important in hypertensive than in normotensive rats (Canadian Journal of Anesthesia 51: 979-985, 2004)
    Jingui Yu, MD*, Koji Ogawa, MD, Yasuyuki Tokinaga, MD*, Shizue Iwahashi, MD* and Yoshio Hatano, MD*
    * From the Department of Anesthesiology, and the Surgical Operating Center, Wakayama Medical University, Wakayama City, Japan.
     

  11. Angiogenesis and Vasculogenesis Are Impaired in the Precocious-Aging klotho Mouse(American Heart Association  Circulation. 2004;110:1148-1155.)
    Toshifumi Shimada, MD; Yoshiaki Takeshita, MD; Toyoaki Murohara, MD; Ken-ichiro Sasaki, MD;
    Kimiyasu Egami, MD; Satoshi Shintani, MD; Yosuke Katsuda, MD; Hisao Ikeda, MD;
    Yo-ichi Nabeshima, MD; Tsutomu Imaizumi, MD
    From the Cardiovascular Research Institute (T.S., Y.T., T.M., K.-i.S., K.E., S.S., Y.K., H.I., T.I.), Kurume University, Kurume; the Department of Cardiology (T.M.), Nagoya University Graduate School of Medicine, Nagoya; and the Department of Pathology and Tumor Biology (Y.-i.N.), Kyoto University Graduate School of Medicine, Kyoto, Japan.
     

  12. Effects of Captoprill on Cardiac and Renal Damage, and Metabolic Alterations in the Nitric Oxide-Deficient Hypertensive Rat (Kidney Blood Pressure Research 2005; 28: 243-250)
    Mahmoud M. Khattab Adel Mostafa Othman Al-Shabanah
    Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh , Saudi Arabia
     

  13. Rat Phenome Project: The untapped potential of existing rat strains  (J Appl Physiol 98: 371-379, 2005)
    Tomoji Mashimo, Birger Voigt, Takashi Kuramoto, and Tadao Serikawa
    Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, Kyoto, Japan
     

  14. An X-Ray Diffraction Study on Mouse Cardiac Cross-Bridge Function In Vivo: Effects of Adrenergic ß-Stimulation (Biophysical Journal 90:1723-1728 (2006)
    Ryuji Toh,* Masakazu Shinohara,* Tomofumi Takaya,* Tomoya Yamashita,* Shigeru Masuda,*
    Seinosuke Kawashima,* Mitsuhiro Yokoyama,* and Naoto Yagiy
    *Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine,Kobe 650-0017, Japan; and ySPring-8/JASRI, Sayo, Hyogo 679-5198, Japan
     

  15. Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice (Am J Physiol Lung Cell Mol Physiol 290: L59-L65, 2006.)
    Shinsuke Murakami,1,2 Noritoshi Nagaya,1,3 Takefumi Itoh,2 Masaharu Kataoka,1 Takashi Iwase,1
    Takeshi Horio,3 Yoshinori Miyahara,4 Yoshiki Sakai,5 Kenji Kangawa,6 and Hiroshi Kimura2
    1Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research
    Institute, Osaka; 2Second Department of Internal Medicine, Nara Medical University, Nara; 3Department of
    Internal Medicine, National Cardiovascular Center, Osaka; 4Department of Cardiac Physiology, National
    Cardiovascular Center Research Institute, Osaka; 5Ono Pharmaceutical Co., Ltd. Research Headquarters,
    Osaka; and 6Department of Biochemistry, National Cardiovascular Center Research Institute, Osaka, Japan

     

  16. Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitory Peptide Obtained from Hen Ovotransferrin (Journal of the Chinese Chemical Society, 2006, 53, 495-501)
    Nai-Yuan Leea, Juei-Tang Chengb, Toshiki Enomotoc, Ichiro Nakamurad,
    a Livestock Research Institute, Tainan 712, Taiwan, R.O.C.
    b Department Pharmacology, College of Medicine, National Cheng Kung University,
       Tainan 70101, Taiwan, R.O.C.
    c Department of Food Science, Ishikawa Prefectural University, Nonoichi, Ishikawa 9218836, Japan
    d Institute of Animal Experimentation, School of Medicine, Hokkaido University, Sapporo 0608589, Japan

    Animal used : SHR
     

  17. Evaluation of Blood Pressure Measured by Tail-Cuff Methods (without Heating) in Spontaneously Hypertensive Rats (Biol. Pharm. Bull. 29(8) 1756-1758 (2006) Vol. 29, No. 8
    KUBOTA Yoko1 UMEGAKI Keizo2 KAGOTA Satomi 3 TANAKA Naoko 4 NAKAMURA Kazuki 5 KUNITOMO Masaru 6 SHINOZUKA Kazumasa 7
    1 Department of Biopharmaceutics, Nihon Pharmaceutical University
    2 National Institute of Health and Nutrition
    3 Department of Pharmacology, School of Pharmaceutical Sciences, Mukogawa Women's University
    4 Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare
    5 Department of Pharmacology, School of Pharmaceutical Sciences, Mukogawa Women's University
    6 Department of Pharmacology, School of Pharmaceutical Sciences, Mukogawa Women's University
    7 Department of Pharmacology, School of Pharmaceutical Sciences, Mukogawa Women's University

     

  18. Mechanical ventilation with 40% oxygen reduces pulmonary expressionof genes that regulate lung development and impairs alveolar septation in newborn mice
    (Am J Physiol Lung Cell Mol Physiol 293:1099-1110, 2007. )
    Richard D. Bland, Lucia M. Mokres, Robert Ertsey, Berit E. Jacobson, Shu Jiang, Marlene Rabinovitch,
    Liwen Xu, Eric S. Shinwell, Feijie Zhang, and Matthew A. Beasley
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California
     

  19. Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice.
    (Am J Physiol Lung Cell Mol Physiol 294:L3-L14, 2008. )
    Richard D. Bland, Robert Ertsey, Lucia M. Mokres, Liwen Xu, Berit E. Jacobson, Shu Jiang,
    Cristina M. Alvira, Marlene Rabinovitch, Eric S. Shinwell, and Anjali Dixit
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California


 


Last Updated: June 06, 2008